Increasing Capacity
Capacity
There is a critical need to empower clinical researchers in Low- and Middle-Income Countries (LMICs) to lead the research response to epidemic infections. We offer a portfolio of research capacity building initiatives to support emerging clinical researchers in exchanging knowledge, gaining confidence in their research and leadership skills, developing local and regional research agendas, and ultimately increasing the international footprint of their institution both within ISARIC and further afield.
Collaboration is at the core of everything we do and our research capacity strengthening programmes focus on reaching out to, and working with a number of regional and international initiatives. Learn more about past and ongoing opportunities.
Clinical Research During Outbreaks (CREDO)
The CREDO training provides trainees with a set of skills to lead the research response in an outbreak, and strengthens the national capacities of LMICs to generate clinical evidence during outbreaks and facilitate networking and the sharing of resources.
Fellowship Programme
Latest news
Successful partners to expand implementation and development of ISARIC Clinical Characterisation Protocol
We are pleased to announce the successful partners from the recent call for partners in the delivery and development of the ISARIC Clinical Characterisation Protocol (CCP). In December 2024, an invitation was sent out to partner in the delivery and development of the ISARIC CCP. The ISARIC CCP is an observational study framework designed to rapidly characterise the clinical epidemiology and pathogenesis of epidemic prone infectious diseases to inform patient care and public health action. ...
Up to £16.5 million awarded to global consortium to overcome obstacles in infectious disease research
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) has been awarded up to £16.5 million to build on its globally-recognised efforts to prevent illness and deaths from epidemic-prone infectious diseases. From the devastating COVID-19 pandemic to the major and growing health problem of dengue – outbreak-prone infectious diseases put lives and livelihoods at risk around the world. ISARIC supports clinical researchers to generate the evidence needed to improve
MOSAIC study provides new insights into mpox clinical outcomes and transmission
The European observational study, MOSAIC, provides evidence on how the clade IIb mpox virus affects patients and the risks of onward transmission In May 2022, a new variant of the mpox virus caused a global outbreak. This variant, known as clade IIb, differs from the mpox typically seen in Africa, particularly in how it spreads and the symptoms it causes. To address the limited availability of clinical evidence regarding mpox and of therapeutic options available to patients, ISARIC has ...